Dr. Thomas Santucci, host of the Medical Insider podcast, is discussing the current state of stem cell regulation, specifically with regards to the FDA and their enforcement of drug designation rules.
As of June 1, 2021, it became illegal to offer stem cells for anything other than a few cancer-related conditions, as the FDA required labs to prove the safety and effectiveness of stem cells through large-scale studies. However, the head of the group controlling regenerative medicine at the FDA was replaced a few months before the end of the trial period, which may have impacted the regulation of stem cells.
Dr. Thomas Santucci also mentions that there is a clear hierarchy of different levels of stem cells, with primary omnipotent stem cells being the best due to their ability to break down into different kinds of cells and ultimately replace damaged tissue.
Additionally, stem cells are naturally anti-inflammatory, which makes them ideal for treating conditions such as rheumatoid arthritis. Dr. Santucci is surprised that nobody has conducted a clinical trial to prove the effectiveness of stem cells, as it would be fairly easy to do so.
Listen to his full podcast below for full details.
Part 1
Part 2